Board of Directors

Dr. Vincent Mutel, Chairman, CEO and co-founder was co-founder, CEO and vice chairman of the board of Addex Pharmaceuticals Ltd, a well-established public Swiss biotech, and prior was Research Area Head in the CNS division at the Swiss pharmaceutical company F. Hoffmann-La Roche Ltd where he worked for 13 years. Vincent is a biochemist and pharmacologist by training and has initiated and successfully driven several R&D projects bringing molecules from discovery to advanced clinical trial. In his role at Addex Pharmaceuticals Ltd he led the growth of the organization to up to 140 staff, completed three rounds of venture financing, an IPO and a PIPE, totaling CHF263 million, and signed three major drug development partnerships, two with Merck & Co., Inc. and one with Ortho-McNeil-Janssen Pharmaceuticals Inc., a Johnson & Johnson company, representing CHF43 million in realized revenues.

Dr. Philippe Meuwly, co-founder, is CEO and co-founder of Pharmalp SA. Philippe was the former Deputy General Manager of OM Pharma, a Swiss-based international bio-pharmaceutical company (500 collaborators worldwide) having successfully developed and commercialized medication of natural origin (representing CHF 70 million CHF in sales, 60% of total sales of the company). At OM Pharma, he established a company wide program management approach leading to the implementation of standardized, company wide project management methods and practices (yearly 25-30 projects worth CHF 60-80 millions and involving overall 50-70 people). This included working in a multicultural environment to lead the Mid-Term Plan of the group. Philippe has 15 years of experience in the pharma/biotech industry and graduated B.Sc. and PhD in Biology from the University of Lausanne and holds a post-graduate degree in business management from HEC Lausanne.

Mr. Levon Khachaturyan, member of the BoD, was deputy general director and contract manager at the Media Holding “E-Media”. Levon was then deputy head of investment banking department, responsible for M&A deals at Nord Capital Group ( More recently, he became representative of BO, member of the board at various companies within the group, project manager at CJSC Investment Company (Imbera). He has a 10 years experience in private equity and M&A deals in Russia and in Europe.

Mr. Oleg Sharonov, member of the BoD is CEO and founder of the Investment Advisory Company “SharonoFF Investment” that is based in Switzerland and active in fields of private equity and real estate. Oleg has 10 years of experience in the financial sector (audit, corporate finance, investment valuation). Experience in the markets of Switzerland, central Europe and Russia with more than 15 successful investment deals in Europe and Russia. Oleg was graduated from Moscow Automobile and Road Construction State Technical University.